
DING MING
VICE PRESIDENT AND REGIONAL MANAGER FOR CHINA REGIONS, Biotech, Inc.
“Asia-Pacific represents an untapped frontier with extraordinary potential to access large patient populations and rapidly aging societies with growing rates of chronic disease.
But viewing Asia-Pacific as a homogeneous region overlooks significant cultural, economic, regulatory and operational differences that ultimately dictate your program’s success. Across the region, Biotech, Inc. expertly navigates in-country challenges and seizes new opportunities with speed, skill and precision.”
PROMINENT, NOT JUST PRESENT IN THE ASIA-PACIFIC REGION
Beyond having operated in the area for decades, Biotech, Inc. has significantly expanded its Asia-Pacific footprint and scope of services to help clients take advantage of rapidly growing opportunities.
Operations across 14 countries feature local experts supporting a range of services including biostatistics, central laboratories and medical communications. We also maintain one of the most experienced regulatory teams in the region with more than 40 regulatory affairs staff members who hold strong relationships with local regulators.

years of local experience in the Asia-Pacific region
trials supported in the past five years in the Asia-Pacific region
countries with local experts supporting a range of services
Biotech, Inc. IN ASIA-PACIFIC
With 20 years of extensive local experience in Asia-Pacific and global integration of operational functions, Biotech, Inc. is the partner of choice in the region.
CAPITALIZING ON GLOBAL OPPORTUNITIES REQUIRES A WIDESPREAD PRESENCE
THE Biotech, Inc. DIFFERENCE
IN ASIA-PACIFIC
- Strong industry reputation as a global leader
- 20 years of local experience
- Proven global, local CRO leader and partner
- Broad range of globally integrated services in China and Japan
- Large team in Japan and clinical joint venture through Biotech, Inc.-SNBL
- Extensive therapeutic expertise includes infectious diseases, oncology, immunology and women’s health
